Prof. Dr. Efnan ALGIN

1. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

Seyyar M., Şancı P. C., Doğan A., Biter S., KÖŞECİ T., Balçık O. Y., et al.

BMC Cancer , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

Buyukaksoy M., Akturk Esen S., TURHAN N., Sahiner E. S., EROĞLU İ., Sert A., et al.

Journal of Clinical Medicine , cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)

3. First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

Seyyar M., Can Şancı P., SAKİN A., Bayramgil A., Dülgar Kaya Ö., SÜNGER E., et al.

Medicina (Lithuania) , cilt.62, sa.5, 2026 (SCI-Expanded, Scopus)

4. Abiraterone Acetate Plus Prednisone Induced Bilateral Avascular Necrosis of the Femoral Head

Sekmek S., ÖZKURT B., Mehtiyev M., BAL Ö., ALGIN E.

Journal of Oncological Science , cilt.12, sa.1, ss.94-97, 2026 (Scopus, TRDizin)

5. A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score

Bayram D., BAL Ö., Karaman K., Bardakçı M., Demirtaş Esmer D., Seven İ., et al.

Current Oncology , cilt.32, sa.4, 2025 (SCI-Expanded, Scopus)

6. Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?

Çakmak M., BAL Ö., Kiraci M., Topaloǧlu O., KÖŞ F. T., ALGIN E.

Anti-Cancer Drugs , cilt.36, sa.2, ss.140-142, 2025 (SCI-Expanded, Scopus)

7. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

Yildirim H. C., BAYRAM E., Chalabiyev E., Majidova N., Avci T., Güzel H. G., et al.

Journal of Chemotherapy , cilt.37, sa.6, ss.551-562, 2025 (SCI-Expanded, Scopus)

8. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Taşçı E. Ş., Oyan B., Sönmez Ö., Mutlu A. U., Atcı M. M., Sakin A., et al.

BMC Cancer , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

9. Clinical features and prognostic factors in thymoma and thymic carcinoma

Bayram D., Sekmek S., Kayaalp M., Bardakçı M., Hafızoğlu E., Uçar G., et al.

Indian Journal of Thoracic and Cardiovascular Surgery , cilt.40, sa.6, ss.660-668, 2024 (ESCI, Scopus)

10. A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

GÜRLER F., Tay F., Sucuoğlu İşleyen Z., Yerlikaya T., Hendem E., Esen S. A., et al.

Cancer Medicine , cilt.13, sa.14, 2024 (SCI-Expanded, Scopus)

11. Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer

ALGIN E., Okudan B., Açıkgöz Y., Sayan H., BAL Ö., Seven B.

Current Medical Imaging , cilt.20, 2024 (SCI-Expanded, Scopus)

12. Major and minor salivary gland cancers: A multicenter retrospective study

HACIOĞLU M. B., ERDOĞAN B., Bardakcı M., ALGIN E., Gulbagcı B., Hacibekiroglu I., et al.

Head and Neck , cilt.45, sa.7, ss.1643-1653, 2023 (SCI-Expanded, Scopus)

13. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Hizal M., Bilgin B., Paksoy N., Atcı M. M., Kahraman S., Kılıçkap S., et al.

Journal of Cancer Research and Clinical Oncology , cilt.149, sa.8, ss.4141-4148, 2023 (SCI-Expanded, Scopus)

14. The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience

ALGIN E., Esen S. A., Acikgoz Y., BAL Ö.

Journal of Cancer Research and Therapeutics , cilt.19, sa.7, ss.2018-2024, 2023 (SCI-Expanded, Scopus)

15. Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data

YILDIRIM C., Acikgoz Y., Ergun Y., ALGIN E., BAL Ö.

Cancer Management and Research , cilt.15, ss.1085-1096, 2023 (SCI-Expanded, Scopus)

Prof. Dr. Efnan ALGIN

Yayınlar & Eserler

1. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

2. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

3. First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

4. Abiraterone Acetate Plus Prednisone Induced Bilateral Avascular Necrosis of the Femoral Head

5. A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score

6. Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?

7. Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

8. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

9. Clinical features and prognostic factors in thymoma and thymic carcinoma

10. A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

11. Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer

12. Major and minor salivary gland cancers: A multicenter retrospective study

13. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

14. The effectiveness of adjuvant treatment approaches for resectable esophageal cancer: A single-center experience

15. Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim